Immunogenicity of IEscherichia coli/I Outer Membrane Vesicles: Elucidation of Humoral Responses against OMV-Associated Antigens

Outer membrane vesicles (OMVs) produced by Gram-negative bacteria have emerged as a novel and flexible vaccine platform. OMVs can be decorated with foreign antigens and carry potent immunostimulatory components. Therefore, after their purification from the culture supernatant, they are ready to be f...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Membranes (Basel) 2023-11, Vol.13 (11)
Hauptverfasser: Croia, Lorenzo, Boscato Sopetto, Giulia, Zanella, Ilaria, Caproni, Elena, Gagliardi, Assunta, Tamburini, Silvia, König, Enrico, Benedet, Mattia, Di Lascio, Gabriele, Corbellari, Riccardo, Grandi, Alberto, Tomasi, Michele, Grandi, Guido
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue 11
container_start_page
container_title Membranes (Basel)
container_volume 13
creator Croia, Lorenzo
Boscato Sopetto, Giulia
Zanella, Ilaria
Caproni, Elena
Gagliardi, Assunta
Tamburini, Silvia
König, Enrico
Benedet, Mattia
Di Lascio, Gabriele
Corbellari, Riccardo
Grandi, Alberto
Tomasi, Michele
Grandi, Guido
description Outer membrane vesicles (OMVs) produced by Gram-negative bacteria have emerged as a novel and flexible vaccine platform. OMVs can be decorated with foreign antigens and carry potent immunostimulatory components. Therefore, after their purification from the culture supernatant, they are ready to be formulated for vaccine use. It has been extensively demonstrated that immunization with engineered OMVs can elicit excellent antibody responses against the heterologous antigens. However, the definition of the conditions necessary to reach the optimal antibody titers still needs to be investigated. Here, we defined the protein concentrations required to induce antigen-specific antibodies, and the amount of antigen and OMVs necessary and sufficient to elicit saturating levels of antigen-specific antibodies. Since not all antigens can be expressed in OMVs, we also investigated the effectiveness of vaccines in which OMVs and purified antigens are mixed together without using any procedure for their physical association. Our data show that in most of the cases OMV–antigen mixtures are very effective in eliciting antigen-specific antibodies. This is probably due to the capacity of OMVs to “absorb” antigens, establishing sufficiently stable interactions that allow antigen–OMV co-presentation to the same antigen presenting cell. In those cases when antigen–OMV interaction is not sufficiently stable, the addition of alum to the formulation guarantees the elicitation of high titers of antigen-specific antibodies.
doi_str_mv 10.3390/membranes13110882
format Article
fullrecord <record><control><sourceid>gale</sourceid><recordid>TN_cdi_gale_infotracmisc_A774323409</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A774323409</galeid><sourcerecordid>A774323409</sourcerecordid><originalsourceid>FETCH-LOGICAL-g679-480d4ca3312cdad647145dd1e38b98764438259288ddcd8f32a1b1695ebae5c53</originalsourceid><addsrcrecordid>eNptjT9rwzAQxUVpoaHNB-gm6OxE_2zJ3UxIG0NCoISsQZbOjootFcseOvWr16UZMvRuuMfj_e4h9ETJgvOcLDvoql57iJRTSpRiN2jGiJQJ4TK9vdL3aB7jB5kmI2nGyQx9l103-tCAd8YNXzjUuFxHc4bembPT2ITWLUu8Hwfo8e7Sg48QnWkhvuB1Oxpn9eCC_2U3Yxd63eJ3iJ_BR4hYN9r5OOD97pgUMQbj9AAWF35wU2l8RHe1biPML_cBHV7Xh9Um2e7fylWxTZpM5olQxAqjOafMWG0zIalIraXAVZUrmQnBFUtzppS1xqqaM00rmuUpVBpSk_IH9Pz3ttEtnJyvw9Br07loToWUgjMuSD6lFv-kprXQORM81G7yr4AfyxRztg</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Immunogenicity of IEscherichia coli/I Outer Membrane Vesicles: Elucidation of Humoral Responses against OMV-Associated Antigens</title><source>DOAJ Directory of Open Access Journals</source><source>PubMed Central Open Access</source><source>MDPI - Multidisciplinary Digital Publishing Institute</source><source>EZB-FREE-00999 freely available EZB journals</source><source>PubMed Central</source><creator>Croia, Lorenzo ; Boscato Sopetto, Giulia ; Zanella, Ilaria ; Caproni, Elena ; Gagliardi, Assunta ; Tamburini, Silvia ; König, Enrico ; Benedet, Mattia ; Di Lascio, Gabriele ; Corbellari, Riccardo ; Grandi, Alberto ; Tomasi, Michele ; Grandi, Guido</creator><creatorcontrib>Croia, Lorenzo ; Boscato Sopetto, Giulia ; Zanella, Ilaria ; Caproni, Elena ; Gagliardi, Assunta ; Tamburini, Silvia ; König, Enrico ; Benedet, Mattia ; Di Lascio, Gabriele ; Corbellari, Riccardo ; Grandi, Alberto ; Tomasi, Michele ; Grandi, Guido</creatorcontrib><description>Outer membrane vesicles (OMVs) produced by Gram-negative bacteria have emerged as a novel and flexible vaccine platform. OMVs can be decorated with foreign antigens and carry potent immunostimulatory components. Therefore, after their purification from the culture supernatant, they are ready to be formulated for vaccine use. It has been extensively demonstrated that immunization with engineered OMVs can elicit excellent antibody responses against the heterologous antigens. However, the definition of the conditions necessary to reach the optimal antibody titers still needs to be investigated. Here, we defined the protein concentrations required to induce antigen-specific antibodies, and the amount of antigen and OMVs necessary and sufficient to elicit saturating levels of antigen-specific antibodies. Since not all antigens can be expressed in OMVs, we also investigated the effectiveness of vaccines in which OMVs and purified antigens are mixed together without using any procedure for their physical association. Our data show that in most of the cases OMV–antigen mixtures are very effective in eliciting antigen-specific antibodies. This is probably due to the capacity of OMVs to “absorb” antigens, establishing sufficiently stable interactions that allow antigen–OMV co-presentation to the same antigen presenting cell. In those cases when antigen–OMV interaction is not sufficiently stable, the addition of alum to the formulation guarantees the elicitation of high titers of antigen-specific antibodies.</description><identifier>ISSN: 2077-0375</identifier><identifier>EISSN: 2077-0375</identifier><identifier>DOI: 10.3390/membranes13110882</identifier><language>eng</language><publisher>MDPI AG</publisher><subject>Antibodies ; Antigens ; B cells ; Escherichia coli ; Medical research ; Medicine, Experimental ; Vaccines ; Viral antibodies</subject><ispartof>Membranes (Basel), 2023-11, Vol.13 (11)</ispartof><rights>COPYRIGHT 2023 MDPI AG</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,864,27924,27925</link.rule.ids></links><search><creatorcontrib>Croia, Lorenzo</creatorcontrib><creatorcontrib>Boscato Sopetto, Giulia</creatorcontrib><creatorcontrib>Zanella, Ilaria</creatorcontrib><creatorcontrib>Caproni, Elena</creatorcontrib><creatorcontrib>Gagliardi, Assunta</creatorcontrib><creatorcontrib>Tamburini, Silvia</creatorcontrib><creatorcontrib>König, Enrico</creatorcontrib><creatorcontrib>Benedet, Mattia</creatorcontrib><creatorcontrib>Di Lascio, Gabriele</creatorcontrib><creatorcontrib>Corbellari, Riccardo</creatorcontrib><creatorcontrib>Grandi, Alberto</creatorcontrib><creatorcontrib>Tomasi, Michele</creatorcontrib><creatorcontrib>Grandi, Guido</creatorcontrib><title>Immunogenicity of IEscherichia coli/I Outer Membrane Vesicles: Elucidation of Humoral Responses against OMV-Associated Antigens</title><title>Membranes (Basel)</title><description>Outer membrane vesicles (OMVs) produced by Gram-negative bacteria have emerged as a novel and flexible vaccine platform. OMVs can be decorated with foreign antigens and carry potent immunostimulatory components. Therefore, after their purification from the culture supernatant, they are ready to be formulated for vaccine use. It has been extensively demonstrated that immunization with engineered OMVs can elicit excellent antibody responses against the heterologous antigens. However, the definition of the conditions necessary to reach the optimal antibody titers still needs to be investigated. Here, we defined the protein concentrations required to induce antigen-specific antibodies, and the amount of antigen and OMVs necessary and sufficient to elicit saturating levels of antigen-specific antibodies. Since not all antigens can be expressed in OMVs, we also investigated the effectiveness of vaccines in which OMVs and purified antigens are mixed together without using any procedure for their physical association. Our data show that in most of the cases OMV–antigen mixtures are very effective in eliciting antigen-specific antibodies. This is probably due to the capacity of OMVs to “absorb” antigens, establishing sufficiently stable interactions that allow antigen–OMV co-presentation to the same antigen presenting cell. In those cases when antigen–OMV interaction is not sufficiently stable, the addition of alum to the formulation guarantees the elicitation of high titers of antigen-specific antibodies.</description><subject>Antibodies</subject><subject>Antigens</subject><subject>B cells</subject><subject>Escherichia coli</subject><subject>Medical research</subject><subject>Medicine, Experimental</subject><subject>Vaccines</subject><subject>Viral antibodies</subject><issn>2077-0375</issn><issn>2077-0375</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2023</creationdate><recordtype>article</recordtype><sourceid/><recordid>eNptjT9rwzAQxUVpoaHNB-gm6OxE_2zJ3UxIG0NCoISsQZbOjootFcseOvWr16UZMvRuuMfj_e4h9ETJgvOcLDvoql57iJRTSpRiN2jGiJQJ4TK9vdL3aB7jB5kmI2nGyQx9l103-tCAd8YNXzjUuFxHc4bembPT2ITWLUu8Hwfo8e7Sg48QnWkhvuB1Oxpn9eCC_2U3Yxd63eJ3iJ_BR4hYN9r5OOD97pgUMQbj9AAWF35wU2l8RHe1biPML_cBHV7Xh9Um2e7fylWxTZpM5olQxAqjOafMWG0zIalIraXAVZUrmQnBFUtzppS1xqqaM00rmuUpVBpSk_IH9Pz3ttEtnJyvw9Br07loToWUgjMuSD6lFv-kprXQORM81G7yr4AfyxRztg</recordid><startdate>20231101</startdate><enddate>20231101</enddate><creator>Croia, Lorenzo</creator><creator>Boscato Sopetto, Giulia</creator><creator>Zanella, Ilaria</creator><creator>Caproni, Elena</creator><creator>Gagliardi, Assunta</creator><creator>Tamburini, Silvia</creator><creator>König, Enrico</creator><creator>Benedet, Mattia</creator><creator>Di Lascio, Gabriele</creator><creator>Corbellari, Riccardo</creator><creator>Grandi, Alberto</creator><creator>Tomasi, Michele</creator><creator>Grandi, Guido</creator><general>MDPI AG</general><scope/></search><sort><creationdate>20231101</creationdate><title>Immunogenicity of IEscherichia coli/I Outer Membrane Vesicles: Elucidation of Humoral Responses against OMV-Associated Antigens</title><author>Croia, Lorenzo ; Boscato Sopetto, Giulia ; Zanella, Ilaria ; Caproni, Elena ; Gagliardi, Assunta ; Tamburini, Silvia ; König, Enrico ; Benedet, Mattia ; Di Lascio, Gabriele ; Corbellari, Riccardo ; Grandi, Alberto ; Tomasi, Michele ; Grandi, Guido</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-g679-480d4ca3312cdad647145dd1e38b98764438259288ddcd8f32a1b1695ebae5c53</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2023</creationdate><topic>Antibodies</topic><topic>Antigens</topic><topic>B cells</topic><topic>Escherichia coli</topic><topic>Medical research</topic><topic>Medicine, Experimental</topic><topic>Vaccines</topic><topic>Viral antibodies</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Croia, Lorenzo</creatorcontrib><creatorcontrib>Boscato Sopetto, Giulia</creatorcontrib><creatorcontrib>Zanella, Ilaria</creatorcontrib><creatorcontrib>Caproni, Elena</creatorcontrib><creatorcontrib>Gagliardi, Assunta</creatorcontrib><creatorcontrib>Tamburini, Silvia</creatorcontrib><creatorcontrib>König, Enrico</creatorcontrib><creatorcontrib>Benedet, Mattia</creatorcontrib><creatorcontrib>Di Lascio, Gabriele</creatorcontrib><creatorcontrib>Corbellari, Riccardo</creatorcontrib><creatorcontrib>Grandi, Alberto</creatorcontrib><creatorcontrib>Tomasi, Michele</creatorcontrib><creatorcontrib>Grandi, Guido</creatorcontrib><jtitle>Membranes (Basel)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Croia, Lorenzo</au><au>Boscato Sopetto, Giulia</au><au>Zanella, Ilaria</au><au>Caproni, Elena</au><au>Gagliardi, Assunta</au><au>Tamburini, Silvia</au><au>König, Enrico</au><au>Benedet, Mattia</au><au>Di Lascio, Gabriele</au><au>Corbellari, Riccardo</au><au>Grandi, Alberto</au><au>Tomasi, Michele</au><au>Grandi, Guido</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Immunogenicity of IEscherichia coli/I Outer Membrane Vesicles: Elucidation of Humoral Responses against OMV-Associated Antigens</atitle><jtitle>Membranes (Basel)</jtitle><date>2023-11-01</date><risdate>2023</risdate><volume>13</volume><issue>11</issue><issn>2077-0375</issn><eissn>2077-0375</eissn><abstract>Outer membrane vesicles (OMVs) produced by Gram-negative bacteria have emerged as a novel and flexible vaccine platform. OMVs can be decorated with foreign antigens and carry potent immunostimulatory components. Therefore, after their purification from the culture supernatant, they are ready to be formulated for vaccine use. It has been extensively demonstrated that immunization with engineered OMVs can elicit excellent antibody responses against the heterologous antigens. However, the definition of the conditions necessary to reach the optimal antibody titers still needs to be investigated. Here, we defined the protein concentrations required to induce antigen-specific antibodies, and the amount of antigen and OMVs necessary and sufficient to elicit saturating levels of antigen-specific antibodies. Since not all antigens can be expressed in OMVs, we also investigated the effectiveness of vaccines in which OMVs and purified antigens are mixed together without using any procedure for their physical association. Our data show that in most of the cases OMV–antigen mixtures are very effective in eliciting antigen-specific antibodies. This is probably due to the capacity of OMVs to “absorb” antigens, establishing sufficiently stable interactions that allow antigen–OMV co-presentation to the same antigen presenting cell. In those cases when antigen–OMV interaction is not sufficiently stable, the addition of alum to the formulation guarantees the elicitation of high titers of antigen-specific antibodies.</abstract><pub>MDPI AG</pub><doi>10.3390/membranes13110882</doi></addata></record>
fulltext fulltext
identifier ISSN: 2077-0375
ispartof Membranes (Basel), 2023-11, Vol.13 (11)
issn 2077-0375
2077-0375
language eng
recordid cdi_gale_infotracmisc_A774323409
source DOAJ Directory of Open Access Journals; PubMed Central Open Access; MDPI - Multidisciplinary Digital Publishing Institute; EZB-FREE-00999 freely available EZB journals; PubMed Central
subjects Antibodies
Antigens
B cells
Escherichia coli
Medical research
Medicine, Experimental
Vaccines
Viral antibodies
title Immunogenicity of IEscherichia coli/I Outer Membrane Vesicles: Elucidation of Humoral Responses against OMV-Associated Antigens
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-01T02%3A09%3A05IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Immunogenicity%20of%20IEscherichia%20coli/I%20Outer%20Membrane%20Vesicles:%20Elucidation%20of%20Humoral%20Responses%20against%20OMV-Associated%20Antigens&rft.jtitle=Membranes%20(Basel)&rft.au=Croia,%20Lorenzo&rft.date=2023-11-01&rft.volume=13&rft.issue=11&rft.issn=2077-0375&rft.eissn=2077-0375&rft_id=info:doi/10.3390/membranes13110882&rft_dat=%3Cgale%3EA774323409%3C/gale%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rft_galeid=A774323409&rfr_iscdi=true